Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection
(2011)
Journal Article
Campbell, S., Campbell, S. A., Alawa, J., Doro, B., Henriquez, F., Roberts, C., Nok, A., Alawa, C., Alsaadi, M., Mullen, A., & Carter, K. (2012). Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection. Vaccine, 30(7), 1357-1363. https://doi.org/10.1016/j.vaccine.2011.12.067
Leishmaniasis is a major health problem and it is estimated that 12 million people are currently infected. A vaccine which could cross-protect people against different Leishmania spp. would facilitate control of this disease as more than one species... Read More about Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection.